Cargando…

A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy

INTRODUCTION: Adult T-cell leukemia/lymphoma (ATL) responds poorly to conventional chemotherapy, but allogeneic stem cell transplantation (allo-SCT) may improve disease prognosis. Herein, we report a female patient with human T-cell leukemia virus type I (HTLV-I)-associated myelopathy (HAM)-like mye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamata, Toyotaka, Ohno, Nobuhiro, Sato, Kota, Kobayashi, Masayuki, Jo, Norihide, Yuji, Koichiro, Tanosaki, Ryuji, Yamano, Yoshihisa, Tojo, Arinobu, Uchimaru, Kaoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197197/ https://www.ncbi.nlm.nih.gov/pubmed/25332881 http://dx.doi.org/10.1186/2193-1801-3-581

Ejemplares similares

Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review
por: Shimada, Naoki, et al.
Publicado: (2017)

Updates on HTLV-1 Uveitis
por: Kamoi, Koju, et al.
Publicado: (2022)

Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient
por: Takeda, Reina, et al.
Publicado: (2020)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

CD4(+)CADM1(+) cell percentage predicts disease progression in HTLV‐1 carriers and indolent adult T‐cell leukemia/lymphoma
por: Makiyama, Junya, et al.
Publicado: (2019)

Early hematopoietic stem cell transplantation improve treatment outcome of aggressive ATL.
por: Uchimaru, Kaoru, et al.
Publicado: (2015)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literature
por: Shimada, Naoki, et al.
Publicado: (2015)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2013)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1
por: Tanaka, Yukie, et al.
Publicado: (2022)

The CD3 versus CD7 Plot in Multicolor Flow Cytometry Reflects Progression of Disease Stage in Patients Infected with HTLV-I
por: Kobayashi, Seiichiro, et al.
Publicado: (2013)

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review
por: Takeda, Reina, et al.
Publicado: (2022)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry
por: Kobayashi, Seiichiro, et al.
Publicado: (2015)

Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population
por: Penova, Marina, et al.
Publicado: (2021)

A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy
por: Ishihara, Makoto, et al.
Publicado: (2015)

A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats
Publicado: (1992)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

A three-factor plasma diagnostic model of human T -cell leukemia virus-1 associated myelopathy
por: Ishihara, Makoto, et al.
Publicado: (2015)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Kodama, Daisuke, et al.
Publicado: (2021)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey
por: Kamoi, Koju, et al.
Publicado: (2019)

Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon
por: Takatani, Massanobu, et al.
Publicado: (2017)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
por: Yamagishi, Makoto, et al.
Publicado: (2018)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
por: McCormick, Matthew, et al.
Publicado: (2011)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy
por: Poondru, Sneha, et al.
Publicado: (2022)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0vo7j3eu1trm67uifd5oe3fc9g